REQUEST A DEMO
Total
USD $0.00
Search more companies

Fresenius Kabi Hungary Kft. (Hungary)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Fresenius Kabi Hungary Vegy-, Gyogyszeripari es Kereskedelmi Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Fresenius Kabi is the leader in infusion therapy and clinical nutrition in Europe and in its most important countries of Latin America and Asia Pacific. Within I.V. generic drugs, Fresenius Kabi counts among the leading suppliers in the U.S. market.
All over the world more than 24,000 employees are committed to improving the quality of life of critically and chronically ill patients with innovative products for patients in hospitals and outpatients.

Headquarters
Szepvolgyi ut 6. III. em.
Budapest; Budapest; Postal Code: 1025

Contact Details: Purchase the Fresenius Kabi Hungary Kft. report to view the information.

Website: http://www.fresenius-kabi.hu

Basic Information
Total Employees:
Purchase the Fresenius Kabi Hungary Kft. report to view the information.
Outstanding Shares:
Purchase the Fresenius Kabi Hungary Kft. report to view the information.
Registered Capital:
Purchase the Fresenius Kabi Hungary Kft. report to view the information.
Financial Auditors:
Purchase the Fresenius Kabi Hungary Kft. report to view the information.
Incorporation Date:
December 15, 1991
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
98%
Purchase this report to view the information.
2%
Company Performance
Financial values in the chart are available after Fresenius Kabi Hungary Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
2.41%
Total operating revenue
1.48%
Operating profit (EBIT)
-6.43%
EBITDA
2.27%
Net Profit (Loss) for the Period
22.1%
Total assets
19.72%
Total equity
15.31%
Operating Profit Margin (ROS)
-0.41%
Net Profit Margin
0.67%
Return on Equity (ROE)
0.74%
Quick Ratio
0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?